Sun Pharma gets FDA approval for diabetes generic drug
REUTERS - Sun Pharmaceutical Industries(SUN.NS) said on Friday it has received final approval from the United States Food and Drug Administration (FDA) to launch the generic version of Novo Nordisk's (NOVOb.CO) Prandin diabetes drug.
Prandin, known chemically as repaglinide, and its combination with the commonly prescribed type 2 diabetes drug metformin, sold as PrandiMet, had sales of about $200 million in 2012 for Novo.
Sun Pharma said it would be eligible for a 180-day marketing exclusivity in the United States for the drug.
A U.S. appeals court last month found the patent on Novo's Prandin diabetes drug in combination with metformin to be invalid, paving the way for the introduction of a generic version of the drug.
(Reporting by Sumeet Chatterjee in MUMBAI; Editing by Supriya Kurane)
- Tweet this
- Share this
- Digg this
- Missing Malaysian jet may have disintegrated in mid-air - source
- UPDATE 4-William Clay Ford Sr., grandson of pioneer automaker, dies at 88
- UPDATE 3-Libyan rebels warn of 'war' if navy attacks oil tanker
- Golf-Reed in Cadillac driver's seat as Woods fades
- WRAPUP 9-Missing Malaysian jet may have disintegrated in mid-air - source
Officials investigating the disappearance of a Malaysia Airlines jetliner with 239 people on board suspect it may have disintegrated in mid-flight, a senior source said on Sunday, as Vietnam reported a possible sighting of wreckage from the plane. Article | Exclusive